News Detail

New Delhi, 21 April 2023: The ceiling price revision and fixation of prices for the new drugs added to the revised Schedule I of the Drugs (Prices Control) Order, 2013, has resulted in an estimated annual savings of over Rs. 3,535 crore in moving annual turnover (MAT) for the con......
View Details
Source : Pharmabiz
ceiling price revision
Schedule I
Drugs (Prices Control) Order 2013
MAT
NPPA
National List of Essential Medicine
NLEM 2022
DPCO 2013
DoP
Related News
- In Sriganganagar and Raisinghnagar, One family is running a dirty business of drugs (22-09-2023)
- Four persons involved in cheating in the name of fake pharma company arrested (22-09-2023)
- Two patients' health deteriorated after injection in Halat Hospital, Kanpur (22-09-2023)
- SEC recommends permission for phase I trial of Cadila Pharma's VZV vaccine (22-09-2023)
- Adding preservatives to ayurvedic medicine will change the classification of medicine (22-09-2023)
- 50 children fell ill after taking filariasis medicine in Purnia (21-09-2023)
- Two smuggling gang youths arrested, one thousand intoxicating pills recovered (21-09-2023)
- FSDA Meerut team raided Transport Godown in Hapur to check consignment of Phensedyl (21-09-2023)
- NMC gets WFME Recognition for 10 Years (21-09-2023)
- Govt approved ₹480 crore to develop talent pool for medical devices sector (21-09-2023)